2006 Oregon Ballot Measure 44

Oregon 2006 Measure 44

2006 Oregon Ballot Measure 44 was a significant piece of legislation in the state of Oregon, United States, that aimed to expand access to prescription drugs through the Oregon Prescription Drug Program. This measure was put to a vote in the general elections held on November 7, 2006.

Background

Prior to the introduction of Measure 44, the Oregon Prescription Drug Program was primarily designed to benefit the elderly and those with low incomes, providing them with access to prescription drugs at discounted rates. However, the program's reach was limited, and many Oregonians found themselves struggling with the high cost of medications.

Provisions

Measure 44 proposed to expand the existing program to allow all Oregon residents, regardless of age or income level, to participate. The measure aimed to leverage the collective bargaining power of the state's population to negotiate better prices for prescription drugs, thereby reducing the overall cost of these medications for participants.

Support and Opposition

The measure received widespread support from various healthcare organizations, patient advocacy groups, and political figures who argued that it would make prescription drugs more affordable and accessible to a larger segment of the population. Opponents of the measure, primarily from the pharmaceutical industry, raised concerns about the potential for increased government intervention in the healthcare market and the possible impact on drug prices and innovation.

Outcome

Measure 44 was passed by a substantial margin, with approximately 77% of voters in favor and 23% opposed. The successful passage of the measure marked a significant step forward in the effort to make prescription drugs more affordable for Oregonians.

Impact

Following its implementation, the expanded Oregon Prescription Drug Program successfully enrolled thousands of additional residents, providing them with access to discounted medications. The program has been credited with not only reducing the cost burden of prescription drugs for individuals but also contributing to a broader discussion on healthcare reform and the role of government in regulating drug prices.

See Also

• Healthcare reform in the United States
• Prescription drug prices in the United States
• Oregon Ballot Measures

This article is a stub related to pharmacology. You can help WikiMD by expanding it!